Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Readers Comments

 Back to Item »

Preliminary Thoughts on the Implications of Prometheus v. Mayo for Biotechnology

1 Readers' Comments

Posted by: Michal Svoboda

07/08/2012

Amidst the general outcry on the Prometheus ruling and sofisticated law finesses the main reason why the patent should never have been granted - obviousness - has never been mentioned.

"Those skilled in the art" know well the therapeutic drug monitoring is widely used for at least half a century (see e.g. a review by S.L.Cohan at http://www.ncbi.nlm.nih.gov/pubmed/6809398). Those skilled in the art also know all too well that if the drug level itself is not a meaningful measure of efficacy or toxicity a suitable metabolite should be sought for.

The takehome lesson for the industry is that we should concentrate on improvement in the method of to determine the drug level, where there is ample field for radical innovation rather than trying to patent the obvious principle.

  • Click here to Login or to Register for free.

    You will be taken back to your selected item after Login/Registration.

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll